Latest news
Loading news…
TransCardiac Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Atlanta, Georgia, United States Founded 2003 11-50 employees For Profit
TransCardiac Therapeutics develops technologies to facilitate access to the human heart.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 2003
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- HQ
- Atlanta, Georgia, United States
- Region
- Greater Atlanta Area, East Coast, Southern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Low
- Growth score
- Medium
- Trend (7d)
- 0
- Trend (30d)
- 0.7
- Trend (90d)
- 0.2
Key People at TransCardiac Therapeutics
Founder
CFO
Founder & VP
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to TransCardiac Therapeutics
Loading news…
FAQs about TransCardiac Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.